Mike gained his BSc in Biochemistry from Kings College London (with a 1 year work placement at Smith, Kline & French Ltd., Welwyn) and his PhD from the University of Liverpool (as a Glaxo Research Studentship). The majority of his career as a researcher has been in the field of oncology, mostly breast cancer and lung cancer. Following a Glaxo sponsored post-doc at Liverpool, he spent 11 years working for Clatterbridge Cancer Research Trust, a small independent research charity associated with Clatterbridge Centre for Oncology. In 2007 he returned to the University of Liverpool and in 2011, secured his current position in the Roy Castle Lung Cancer Research Programme with Prof John Field and Dr Lakis Liloglou. Having participated in the EU FP7 CURELUNG & LCAOS research projects, he currently heads the Clincial Resources group and manages the Liverpool Lung Project biorepository. His main research focus is discovery and validation of biomarkers for early detection of lung cancer and treatment stratification.